Your browser doesn't support javascript.
loading
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
Hitchins, Megan P; Alvarez, Rocio; Zhou, Lisa; Aguirre, Francesca; Dámaso, Estela; Pineda, Marta; Capella, Gabriel; Wong, Justin J-L; Yuan, Xiaopu; Ryan, Shawnia R; Sathe, Devika S; Baxter, Melanie D; Cannon, Timothy; Biswas, Rakesh; DeMarco, Tiffani; Grzelak, Doreen; Hampel, Heather; Pearlman, Rachel.
Affiliation
  • Hitchins MP; Department of Biomedical Sciences, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Medicine (Oncology), Stanford University, Stanford, CA, USA. Electronic address: megan.hitchins@cshs.org.
  • Alvarez R; Department of Biomedical Sciences, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Zhou L; Department of Biomedical Sciences, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Aguirre F; Department of Biomedical Sciences, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Dámaso E; Department of Medicine (Oncology), Stanford University, Stanford, CA, USA; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Av. Gran Via de l'Hospitalet, 199-203, 08908 L' Hospitalet de Llobregat, Barcelona, Spain;
  • Pineda M; Molecular Genetics Unit, Elche University Hospital, Elche, Alicante. Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), FISABIO- Elche Health Department, Spain; Consortium for Biomedical Research in Cancer - CIBERONC, Carlos III Institute of Health, Av. De M
  • Capella G; Molecular Genetics Unit, Elche University Hospital, Elche, Alicante. Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), FISABIO- Elche Health Department, Spain; Consortium for Biomedical Research in Cancer - CIBERONC, Carlos III Institute of Health, Av. De M
  • Wong JJ; Epigenetics and RNA Biology Program Centenary Institute, and Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales 2050, Australia.
  • Yuan X; Department of Pathology and Laboratory Medicine, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Ryan SR; Hereditary Cancer Assessment Program, University of New Mexico Comprehensive Cancer Center, NM, USA.
  • Sathe DS; Precision Medicine and Genetics, Frederick Health, MD, USA.
  • Baxter MD; Saint Francis Healthcare System, Cape Girardeau, MO, USA.
  • Cannon T; Cancer Genetics Program, Inova Schar Cancer Institute, Inova Fairfax Hospital, VA, USA.
  • Biswas R; Cancer Genetics Program, Inova Schar Cancer Institute, Inova Fairfax Hospital, VA, USA.
  • DeMarco T; Cancer Genetics Program, Inova Schar Cancer Institute, Inova Fairfax Hospital, VA, USA.
  • Grzelak D; Virginia Cancer Specialists, Fairfax, VA, USA.
  • Hampel H; Department of Internal Medicine and the Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA; Division of Clinical Cancer Genomics, Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.
  • Pearlman R; Department of Internal Medicine and the Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA.
Gynecol Oncol ; 171: 129-140, 2023 04.
Article in En | MEDLINE | ID: mdl-36893489

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Endometrial Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Endometrial Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2023 Type: Article